Beximco Pharmaceuticals PLC. (DSE:BXPHARMA)
Bangladesh · Delayed Price · Currency is BDT 117.00
0.00 (0.00%)
At close: Mar 24, 2026
DSE:BXPHARMA Market Cap
DSE:BXPHARMA has a market cap or net worth of 52.2 billion as of March 24, 2026. Its market cap has increased by 53.54% in one year.
Market Cap
52.20B
Enterprise Value
59.49B
Revenue
46.34B
Ranking
n/a
PE Ratio
8.22
Stock Price
117.00
Market Cap Chart
Since January 3, 2000, DSE:BXPHARMA's market cap has increased from 1.91B to 52.20B, an increase of 2,631.42%. That is a compound annual growth rate of 13.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 52.20B | 14.59% |
| Dec 30, 2025 | 45.55B | 25.12% |
| Dec 30, 2024 | 36.40B | -44.19% |
| Dec 28, 2023 | 65.22B | - |
| Dec 29, 2022 | 65.22B | -24.13% |
| Dec 30, 2021 | 85.97B | 1.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Square Pharmaceuticals PLC. | 192.63B |
| Renata | 49.77B |
| Unilever Consumer Care | 42.14B |
| Beacon Pharmaceuticals | 23.54B |
| The ACME Laboratories | 16.55B |
| The IBN SINA Pharmaceutical Industry | 10.03B |
| Asiatic Laboratories | 8.53B |
| Orion Pharma | 6.83B |